Adlyfe
Rockville
About Adlyfe
Adlyfe is a biotechnology company founded in the spring of 2003 to bring to market innovative diagnostic products for neurodegenerative diseases. These diseases are correlated to changes in protein conformation, as normally soluble proteins fold into conformations that aggregate and deposit in brain tissue, a process known as amyloidogenesis. Over time, the accumulation of these misfolded and aggregating proteins results in loss of neural cells and brain tissue, and associated symptoms including dementia, motor dysfunction, and other fatal symptoms.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.3M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Feb 2013)
- Website: adlyfe.com
- Phone: +1 703-868-3050
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Neuroscience
Canonical: https://fsome.com/organization/adlyfe-2638568 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.